ArticleMolecular therapy. Nucleic acids2023

Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression.

Kang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.